Note 21: Earnings Per Share

The factors used in the earnings per share computation for the periods indicated are presented below:

 

 

For the Year Ended December 31,

 

 

2025

 

 

2024

 

 

Net Income
(Numerator)

 

 

Common
Shares Weighted Average Outstanding
(Denominator)

 

 

Per
Share

 

 

Net Income
(Numerator)

 

 

Common
Shares Weighted Average Outstanding
(Denominator)

 

 

Per
Share

 

Basic net income per
   common share

 

$

15,826

 

 

 

6,359,960

 

 

$

2.49

 

 

$

7,623

 

 

 

6,161,428

 

 

$

1.24

 

Dilutive shares(1)

 

 

 

 

 

2,545

 

 

 

 

 

 

 

 

 

2,182

 

 

 

 

Diluted net income per
   common share

 

$

15,826

 

 

 

6,362,505

 

 

$

2.49

 

 

$

7,623

 

 

 

6,163,610

 

 

$

1.24

 

 

(1)
RSA grants are disregarded in the computation of diluted earnings per share if they are determined to be anti-dilutive. There were no anti-dilutive RSAs for the years ended December 31, 2025 or December 31, 2024.

Historical Timeline

Fiscal YearFiled
2025Mar 27, 2026Showing above
2024Mar 28, 2025
2023Mar 19, 2024

About Earnings Per Share Disclosures

The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.

Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.